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The pathogenesis of acute pancreatitis is incom- 
pletely defined, but the outcome is determined in part 
by an acute inflammatory process. Pancreatitis-asso- 
ciated inflammation appears to play a role in the local 
retroperitoneal injury as well as in the associated dys- 
function of remote organs such as the lung. Tumor ne- 
crosis factor (TNF) appears to be a proximal mediator 
of the inflammatory response. In this study, anti-TNF 
antibody was administered to rats with caerulein-in- 
duced pancreatitis to determine if the observed in- 
creases in pancreatic and pulmonary microvascular 
permeability were related to plasma TNF activity. In 
contrast to the expected findings, blockade of TNF ac- 
tivity was found to increase the amount of edema for- 
mation in both the pulmonary and pancreatic microvas- 
cular beds. The mechanism is not known; however, 
blockade of TNF-induced down regulation of phago- 
cytic cell activity, ablation of TNF-dependent feedback 
inhibition of other cytokines, failure of induction of en- 
dogenous antioxidant systems, or inactivation of the 
TNF control of microvascular tone are all possible ex- 
planations. This is potentially an important observa- 
tion as clinical strategies are now being developed to 
modify the inflammatory response in ways presumed 
advantageous to an injured host. o 1991 Academic press, I~C. 
INTRODUCTION 
Acute pancreatitis is an enigmatic clinical process 
which is typically associated with local edema formation 
and acute inflammation. Some patients develop progres- 
sive pancreatic necrosis and multiorgan system failure. 
The factors which regulate these processes are un- 
known. An important mediator of the inflammatory pro- 
cess in other experimental injury models is tumor necro- 
sis factor CY (TNF) [l]. TNF is derived from activated 
macrophages and appears to have important effects 
1 Presented at the Annual Meeting of the Association for Academic 
Surgery, Houston, TX, November 14-17, 1990. 
’ Supported in part by NIH Grants HL38141 and GM41745. 
upon the microvasculature. In particular, TNF appears 
to increase microvascular permeability by virtue of sev- 
eral effects upon the endothelial cell. TNF-mediated en- 
dothelial cell permeability increases have been related in 
vitro to the induction of membrane adhesion molecules 
which provide a means for neutrophil adherence and 
subsequent injury to occur. In addition, the secretion of 
interleukins 1 (IL-l) and 6 (IL-6), increased synthesis of 
prostaglandin I, (prostacyclin), and direct morphologi- 
cal alterations of endothelial cells all result from expo- 
sure to TNF [2]. 
Caerulein-induced acute pancreatitis in rats is asso- 
ciated with endothelial cell injury and edema formation 
in both the pancreatic and pulmonary microvasculature 
[3-51. This appears to be neutrophil related. The pur- 
pose of this study was to evaluate whether TNF is a 
mediator of edema formation in this model of caerulein- 
induced acute pancreatitis. The data suggest that TNF 
is involved in the process of both pancreatic and lung 
edema formation, although not simply as a noxious medi- 
ator. 
MATERIALS AND METHODS 
Animal Model 
All experimental protocols received prior approval 
from the University of Michigan Committee for the Use 
and Care of Animals. Male Sprague-Dawley rats (150- 
200 g, Charles River, Portage, MI) were anesthetized 
using ketamine hydrochloride (100 mg/kg body weight) 
given subcutaneously. Silastic central venous catheters 
were placed by cutdown into the jugular vein and tun- 
neled to exit the dorsal cervical region of each rat. The 
rats were allowed to recover overnight. The following 
day, rats were assigned to receive either caerulein (5 pg/ 
kg/hr, Sigma Chemical Co., St. Louis, MO) or sterile 
normal saline solutions using a continuous intravenous 
infusion of 2 ml/hr (Pump 22, Harvard Co., South Na- 
tick, MA). This caerulein dose is known to induce acute 
edematous pancreatitis in rats [6]. Rats were infused for 
0.5,1,3,6, or 12 hr. After completion of infusion, the rats 
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were sacrificed and venous blood was obtained for TNF 
assay. 
In the second portion of the experiment, rats were 
prepared with central venous catheters as described 
above. Prior to infusion, rats received an intravenous 
injection (1 cc) of either rabbit-derived anti-TNF anti- 
serum (anti-TNF) or normal rabbit serum (NRS) 
(serum and antiserum diluted 1:l with sterile normal 
saline prior to injection). Three hours prior to sacrifice, 
each animal received a 1 ml intravenous bolus of [1251]- 
bovine serum albumin (BSA, 800,000 cpm/ml). After 3 
or 12 hr of caerulein infusion, ketamine hydrochloride 
(100 mg/kg body weight) was administered subcutane- 
ously and laparotomy was performed. One milliliter of 
blood was aspirated from the inferior vena cava, the 
heart and lungs were quickly excised, the pancreas was 
removed, and the animals were exsanguinated. Twenty 
milliliters of sterile saline was infused into the right ven- 
tricle to wash residual blood and lz51-BSA from the pul- 
monary vascular bed. Done quickly, a spontaneous heart 
beat persisted, the pulmonary parenchyma blanched, 
and the effluent became asanguinous. The blood sample, 
pancreas, and lungs were then counted in a gamma scin- 
tillation counter. Results are expressed as a permeability 
index (number of 125I counts in tissue divided by the 
number of 1251 counts in the blood) for each rat. This 
ratio reflects albumin sequestration in tissue and is thus 
correlated with microvascular permeability [3, 41. 
Assay for Plasma TNF Activity 
TNF activity was determined using the WEHI 164, 
subclone 13 cell line. This bioassay, which depends upon 
the lytic effect of TNF on this mouse fibrosarcoma line 
is the most sensitive available assay (capable of detect- 
ing approximately 1 pg/ml of TNF) [7-91. Briefly, 
plasma samples were serially diluted and placed in 96- 
well microtiter plates (Costar, Cambridge, MA). The 
WEHI cells were resuspended at 5 X lo5 cells/ml in 
RPM1 1640,10% fetal calf serum, 1 mM L-glutamine, 0.5 
ml actinomycin D (Calbiochem, La Jolla, CA), and added 
to the diluted test samples (100 PI/well). The plates were 
incubated at 37°C and 5% CO, for 20 hr. Following incu- 
bation, 20 ml of MTT-tetrazolium (5 mg/ml, Sigma) in 
phosphate-buffered saline was added to each well and 
the plates were reincubated for 4 additional hr. After the 
second incubation, 100 ml of 0.04 N HCl/isopropanol 
was added to each well to dissolve the purple formazine 
crystals. Plates were stored overnight in the dark and 
then read at 550 nm on a Bio-Kinetics Reader (Bio-Tek 
Instruments, Inc., Winoski, VT). Readings were com- 
pared to a standard curve generated using human recom- 
binant TNF (Cetus Corp., Emeryville, CA) and data are 
expressed as units/ml. Confirmation of the cytotoxicity 
of plasma TNF in the positive samples was achieved by 
neutralization with a polyclonal rabbit antimurine TNF 
antiserum (anti-TNF antibody) which cross-reacts with 
rat TNF. 
A polyclonal rabbit antimurine-TNF antiserum (anti- 
TNF) was used to assess the effects of TNF blockade on 
microvascular permeability in both the pulmonary and 
pancreatic vascular beds. The antibody neutralizes both 
recombinant and natural TNF and cross-reacts with rat 
TNF [9]. At a dilution of l:lO,OOO the antibody will com- 
pletely neutralize 10 units of rat TNF. (Twenty two 
units equal 1 ng of TNF). 
Endotoxin Assay 
The absence of endotoxin in this experimental model 
was confirmed using a commercial limulus amebocyte 
lysate assay (Whittaker MA Bioproducts, &CC-l000 
TM, Walkersville, MD). Plasma samples for endotoxin 
measurement were taken simultaneously with samples 
for TNF measurement. Briefly, 1 ml of blood from the 
inferior vena cava was drawn into a heparinized syringe 
and lysate inhibitory factors were removed by pretreat- 
ment with 2.53% HClO, and 0.2 N NaOH. The assay 
depends upon bacterial endotoxin to activate a proen- 
zyme in the limulus amoebocyte lysate which catalyzes 
the cleavage of p-nitroanaline (pNA) from the colorless 
substrate. The pNA is assayed spectrophotometrically 
at 405 nm and provides a quantitative analysis of endo- 
toxin content. Samples were compared to the absorption 
of serially diluted reference endotoxin standards (Esche- 
richia coli endotoxin 0111; B4, Difco, Detroit, MI). 
Statistical Analysis 
Data are expressed as means +_ standard error of the 
mean. A one-way analysis of variance (ANOVA) was 
used with post hoc comparison using Fisher’s protected 
least squares difference to analyze the data. Significance 
was assigned when P -C 0.05. 
RESULTS 
Plasma TNF was measured in systemic blood to de- 
termine whether significant elevations occurred in this 
model of acute pancreatitis. The data in Fig. 1 illustrate 
a stepwise increase in systemic plasma TNF levels dur- 
ing the induction of acute pancreatitis. Only small 
amounts of TNF (0.13 + 0.09 units/ml) are detectable in 
the plasma of rats prior to caerulein infusion (Time 0). 
Plasma levels begin to rise by 60 min of caerulein infu- 
sion (0.32 +- 0.09 units/ml) and by 180 min of caerulein 
infusion, there is a fourfold increase (P -C 0.05) in TNF 
levels compared to controls. Previous data demonstrate 
well-established acute edematous pancreatitis at 3 hr 
with more severe disease including focal pancreatic ne- 
crosis after 12 hr [3, 5,6]. Plasma TNF levels after 6 hr 
returned to near baseline levels; however, a biphasic re- 
sponse is apparent when the infusions continued to 12 
hr. In separate experiments using infusions of 12 hr dura- 
tion, plasma TNF levels were increased fourfold in ani- 
mals with caerulein-induced acute pancreatitis com- 
GUICE ET AL.: EDEMA FORMATION AND ANTI-TNF 497 
0.6 
0 30 60 160 360 
TIME (min) 
FIG. 1. Plasma TNF levels following the induction of caerulein- 
induced acute pancreatitis. Prior to the onset of acute pancreatitis 
(Time 0) there is little TNF present (0.31 + .09 units/ml). After 180 
min there is a fourfold increase in the amount of TNF present (P < 
0.05). 
pared to saline infused controls (11.08 + 6.06 units/ml 
versus 3.07 & 1.28 units/ml, respectively, P -e 0.05). Be- 
cause the WEHI 164 assay is a bioassay, absolute TNF 
values are variable, reflecting day to day changes in the 
cytotoxicity threshold of the fibrosarcoma target cells. 
Therefore, quantitative comparisons require concurrent 
controls (as provided), but are not possible between ex- 
periments. For this reason, these data and the data in 
Fig. 1 can be compared only qualitatively. In this regard, 
a consistent biphasic pattern is observed with an early 
TNF peak (l-3 hr), returning to near normal (6 hr) and 
a later TNF peak (12 hr) among experimental animals 
with caerulein-induced acute pancreatitis. 
Plasma was assayed for endotoxin to ensure that these 
TNF elevations were not secondary to endotoxin, a po- 
tent stimulus of TNF release. No endotoxin was de- 
tected in any control or experimental samples (data not 
shown). 
Data showing pancreatic edema formation are shown 
in Figs. 2 and 3. After 3 hr (Fig. 2) or 12 hr (Fig. 3) of 
caerulein infusion, there was a significant increase in 
pancreatic edema formation in all animals with caeru- 
lein-induced pancreatitis compared to normal saline-in- 
fused control animals. The experimental group receiving 
caerulein and anti-TNF antibody had an additional sig- 
nificant increase in pancreatic edema formation com- 
pared to the groups receiving caerulein alone or caeru- 
lein plus normal rabbit serum. 
Lung edema formation is shown in Fig. 4 (3-hr caeru- 
lein infusion) and Fig. 5 (12-hr caerulein infusion) as the 
edema index. Lung edema formation in the groups re- 
NS c C+NRS C+aTNF 
FIG. 2. Pancreas permeability after 3 hours of infusion is repre- 
sented by the edema index (the number of counts in tissue/the num- 
ber of counts in blood). A significant increase in edema occurs in the 
caerulein (C) group, the caerulein + normal rabbit serum (C + NRS) 
group, and the caerulein + anti-TNF (C + (uTNF) group compared to 
the normal saline group. In addition there is a significant increase in 
the amount of edema present in the C + cvTNF group compared to the 
C or the C + NRS group (*P < 0.05). 
ceiving caerulein and anti-TNF antibody was signifi- 
cantly (P < 0.05) increased over all the other groups at 
both the 3- and 12-hr time points. 
DISCUSSION 
The roles of cytokines in general and, TNF in particu- 
lar, are not clearly defined in the inflammatory process 
NS C C+NRS C+aTNF 
FIG. 3. After 12 hr of caerulein infusion, the increase in pancre- 
atic edema formation seen at 3 hr of infusion remains. There is a 
significant increase in the amount of edema present in the C + (uTNF 
group compared to all other groups (*P < 0.05). 
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FIG. 4. Lung edema in the group receiving C + (uTNF is signifi- 
cantly increased over the C and the C + NRS groups after 3 hr of 
caerulein infusion. 
which accompanies caerulein-induced acute pancreati- 
tis. TNF-mediated effects on neutrophil and endothelial 
cell function are described in other experimental sys- 
tems and are usually associated with an increase in mi- 
crovascular permeability. These effects include the in- 
duction of adhesive surface molecules on endothelial cell 
membranes, a neutrophil chemotactic response, neutro- 
phi1 activation, cytokine-cytokine interactions, and un- 
doubtedly others not yet elucidated 121. In addition, 
TNF-induced oxidant generation by phagocytic cells 
may play a role in this model, as it is known that pancre- 
atic injury is in part oxygen radical mediated [3]. The 
physiological response of endothelial ceI1 exposure to 
TNF is an increase in microvascular permeability. 
Given these published data, the initial findings in this 
study of parallel increases in plasma TNF levels and the 
degree of edema formation in lung and pancreas were 
expected. However, the development of significant addi- 
tional edema formation after anti-TNF antibody pre- 
treatment was not anticipated. The mechanisms respon- 
sible for this apparent paradox are not known nor is the 
explanation for the early and late TNF peaks. With re- 
gard to the latter, presumably clearance of the early 
TNF peak is followed by a second proinflammatory stim- 
ulus. 
Gordon and Sheppard demonstrated that small doses 
of endotoxin or recombinant human TNF prevented air- 
way edema formation in guinea pigs exposed to 80% tolu- 
ene 2,4-diisocyanate, 20% toluene 2,6diisocyanate [lo]. 
In this report, airway edema formation was not pre- 
vented when anti-TNF antibody or heat-inactivated 
TNF were given. The authors speculated that TNF may 
inhibit airway edema formation by nonspecifically alter- 
ing or inhibiting the ability of neutrophils or endothelial 
cells to respond to a subsequent inflammatory challenge. 
Mier and colleagues found that TNF pretreatment of 
cultured human endothelial cells derived from the sa- 
phenous vein prevented diffusion of labeled BSA when 
the cells were subsequently treated with lymphokine-ac- 
tivated killer cells [ll]. Their results suggest that TNF 
may protect endothelial cells from interleukin 2-induced 
capillary leak. 
The data from the current study suggest that TNF is 
indeed involved in the process of edema formation and 
endothelial cell injury in this model. Edema formation is 
significantly enhanced in both lungs and pancreatic tis- 
sue in caerulein-inducedpancreatitis when TNF activity 
is blocked with specific antibody. This suggests that 
some endogenous TNF-mediated inhibitory process is 
altered when TNF activity is blocked. Possible explana- 
tions include (1) loss of TNF-induced down regulation of 
inflammatory effector cells, (2) blockade of TNF-me- 
diated feedback inhibition, perhaps involving other cy- 
tokines such as IL-2, (3) failure of endogenous antioxi- 
dant induction, or (4) alterations in the regulation of 
TNF-mediated microvascular tone. 
In summary, our findings suggest that plasma TNF 
may participate in a sequence of regulatory events that 
determine the degree of lung and pancreatic microvascu- 
lar permeability increase associated with this model of 
caerulein-induced acute pancreatitis. The importance of 
the observation is that evolving therapeutic strategies 








NS C C+NRS C+aTNF 
FIG. 5. After 12 hr of caeruiein infusion, a significant elevation in 
lung edema persists in the C + aTNF group compared to the C or the 
C + NRS groups (*P < 0.05). 
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